Clinical Trial Update: The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of dual RAAS blockade with valsartan and aliskiren in African American patients with hypertension and metabolic syndrome has been withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Metabolic Syndrome

Drugs mentioned

• Aliskiren (Aliskiren)
• VALSARTAN (Valsartan)

Snippet

Sponsor: University of Michigan | Conditions: Hypertension, Metabolic Syndrome | Phase 1 | Status: WITHDRAWN